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Cardiac
Resynchronization Therapy
Location Matters*
Kenneth A. Ellenbogen, MD, Jordana Kron, MD
Richmond, Virginia
In this issue of the Journal, Giraldi et al. (1) compare
transvenous and epicardial lead placement in patients with
unfavorable coronary sinus anatomy. Patients who met
standard criteria for cardiac resynchronization therapy
(CRT) including left ventricular (LV) dysfunction, New
York Heart Association class III to IV congestive heart
failure, and left bundle branch block, who were on optimal
medical therapy underwent pre-operative multislice com-
puted tomography to evaluate coronary sinus (CS) anatomy.
Patients with CS veins that were absent, tortuous, angled
acutely, or very small were prospectively randomized to LV
lead implantation by epicardial minimally invasive thoracot-
omy versus conventional endocardial lead placement.
See page 483
Whereas the surgically positioned leads were placed over
the mid-basal segments of the posterolateral LV wall, the
transvenously positioned leads could not be placed in
these segments because of suboptimal CS anatomy. At 1
ear, the surgical patients, but not the patients implanted
ransvenously, had significant improvements in New York
eart Association functional class, LV ejection fraction, LV
nd-systolic volume, and peak VO2/kg.
In this small but well-designed trial, Giraldi et al. (1) set
ut to answer an important clinical question: How should
n electrophysiologist treat a heart failure patient who needs
RT but has challenging CS anatomy? The answer to this
uestion relies on gaining deeper understanding about
lectrical and mechanical dyssynchrony. In a landmark
rticle using contact and noncontact mapping to study LV
ctivation, Auricchio et al. (2) demonstrated the complexity
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ctivation of the LV was “U-shaped” in 23 patients because
f an anterior, lateral, or inferior line of block, which
emonstrated functional behavior. The location of the line
f block was unpredictable and independent of QRS dura-
ion. Varma et al. (3) used noncontact body surface mapping
o examine electrical synchrony in 8 patients undergoing
RT and found that although the location of latest LV
ctivation was in the lateral LV base in 3 patients, it was
ariable in the remaining patients. The effect of fibrosis on
esponse to LV pacing is also poorly understood, but in 1
tudy was found to have an important negative effect on
esponse to CRT (4).
Several recent studies have provided insight into CRT
nd LV lead location that have shattered previous assump-
ions about this complex matter. Despite impressive benefits
rom CRT in some patients, 20% to 40% of patients are
onresponders. Many explanations for nonresponders exist,
ncluding poor patient selection or suboptimal execution of
herapy (5). At Late-Breaking Clinical Trials at Heart
hythm 2010, Singh et al. (6) presented long-term
ollow-up from a substudy of MADIT-CRT (Multicenter
utomatic Defibrillator Implantation Trial-Cardiac Resyn-
hronization Therapy) evaluating the impact of LV lead
osition on clinical outcomes. In 799 patients randomized
o CRT-D, LV lead location was classified along the short
xis as anterior, lateral, or posterior and along the long axis
s basal, mid-ventricular, or apical based on venograms and
hest radiographs. Patients whose LV lead was positioned
pically had a 22% risk of heart failure and mortality versus
12% risk in patients with a mid-ventricular or basal lead
osition. Furthermore, there was no difference in clinical
enefit or outcome between patients with LV leads posi-
ioned on the anterolateral or posterior walls. This finding is
mportant because response to therapy was not measured by
cute changes in hemodynamic parameters, but rather by
ong-term changes in LV volumes. Merchant et al. (7)
rospectively evaluated LV lead position along the longitu-
inal axis in 115 patients at a single center. The primary
ndpoint was a composite outcome of heart failure hospi-
alization, cardiac transplantation, or all-cause mortality.
uring a mean follow-up of 15 months, the primary
ndpoint of event-free survival was significantly lower (52%
s. 79%) in the patients with apical LV leads. These findings
uggest that apical placement of LV leads should be
voided. In the present study (1), 11 of the 20 patients who
eceived a transvenous device had the LV lead placed in an
pical posterior vein.
Other recent studies also challenge the assumption that
osterolateral lead placement is the only ideal location.
eim et al. (8) prospectively evaluated 102 patients who
eceived CRT to define demographic, clinical, and electro-
ardiographic predictors of CRT response. Independent
redictors of a clinical response included an idiopathic
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CRT: Location Matters July 26, 2011:491–2etiology of cardiomyopathy, wider QRS prior to implanta-
tion, and narrowing of the QRS after implantation. Inter-
estingly, the anatomic position of the LV lead did not
predict clinical benefit from CRT, suggesting that the
lateral wall may not be the optimal pacing site in all patients.
In a retrospective analysis of 32 super-responders to CRT,
defined as patients in whom ejection fraction improved by
20%, lead position was not a significant predictor of
super-response, but there were trends toward super-
responders having more midventricular and fewer laterally
placed leads (9). One explanation may be the presence of
fibrosis at the pacing site. Lambiase et al. (10) performed
noncontact mapping on 10 patients with biventricular
pacemakers, all with the LV lead in a posterolateral location.
In 6 patients, 5 with ischemic heart disease, the CS lead was
positioned at a site with low amplitude electrograms and
slow conduction velocity. Even when the LV lead is
positioned in an area of late mechanical or electrical activa-
tion, the benefits of biventricular pacing may be limited if
the lead is located in an area of myocardial scar or substan-
tial electrical delay.
With regard to LV lead position in biventricular pacing
systems, the study from Giraldi et al. (1) suggests that at
least in some patients, LV lead location does matter. Al-
hough the present paper by Giraldi et al. (1) advances the
urrent state of knowledge on this important topic, there is
till a lot we do not know about mechanical and electrical
yssynchrony in heart failure. For example, we do not know
hether LV lead position should be dictated by electrical
atency or mechanical latency. We have only recently
earned in an elegant paper from the Bordeaux group (11)
hat endocardial pacing is associated with significantly
etter hemodynamics than epicardial pacing is, and the
ptimal site of endocardial pacing was not predicted by
echanical latency or typically found to be in the lateral
all. Further research is needed in this critical area. Evolv-
ng technologies and implant techniques, such as CS
enoplasty, may also improve outcomes by allowing access
o more optimal pacing sites. Finally, caution must be taken
efore recommending routine CT scans to define anatomy
n candidates for CRT, as was performed in the present
tudy. Iatrogenic radiation exposure has become an impor-
ant concern and cardiac patients often have multiple
xposures in the cardiac stress, catheterization, and electro-
hysiology laboratories (12,13). Fluoroscopy times during
RT implants can be prolonged and the long-term risks of
erforming a CT scan in addition are unknown. We are just
eginning to understand the complexity of LV activation in reart failure patients and in patients with biventricular
acing. While we await the results of future trials, we do not
eel a change in clinical practice is warranted based on the
urrent state of knowledge, and we do not endorse pre-
rocedural CT scans because of concern about increased
adiation exposure.
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